RARE
Ultragenyx
14.50$
-4.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -121,033.8% | -9,718.3% | -564.3% | -333.0% | -48.8% | -96.4% | -104.7% | -109.3% | -73.9% | -69.2% | |
| – | – | 2,574.4% | 223.0% | 37.9% | 8.2% | 4.5% | 3.8% | 5.0% | 6.0% | 6.3% | 5.2% | |
| – | – | 36,322.6% | 2,603.9% | 155.6% | 79.1% | 31.6% | 29.9% | 35.9% | 31.1% | 28.2% | 22.7% | |
| – | – | 41,483.5% | 2,400.5% | -165.2% | 80.3% | 0.3% | 0.1% | 20.6% | – | – | – | |
| – | – | 19,775.9% | -774.5% | -48.1% | -15.4% | 38.6% | -18.0% | 16.6% | -3.5% | 2.5% | -3.4% | |
| – | – | 7,660.2% | 106.9% | 7.9% | 23.9% | 16.2% | 20.8% | 40.2% | 10.8% | 1.3% | 0.9% | |
| – | – | 67,605.3% | 2,159.9% | -64.7% | -12.6% | -66.1% | -55.6% | -80.3% | 38.7% | -3.2% | 35.1% | |
| – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | 65,654.1% | 5,406.2% | 580.2% | 328.1% | 193.6% | 11.4% | 3.0% | – | – | – | |
| – | – | -3,717.3% | -189.3% | – | – | – | – | – | – | – | – | |
| – | – | 104,267.7% | 5,217.0% | 654.1% | 655.0% | 221.5% | 33.7% | 137.9% | 89.4% | 71.3% | 71.0% | |
| – | – | 50,790.2% | -2,321.3% | 24.2% | 309.2% | 107.0% | -118.6% | -47.3% | 18.8% | -6.3% | 37.7% | |
| – | – | -128,694.0% | -9,825.3% | -572.2% | -357.0% | -65.0% | -117.2% | -144.9% | -120.1% | -75.3% | -70.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.